Genetic Engineering - A Non-Toxic Treatment for Leukemia
A novel form of genetic engineering produced fantastic results against leukemia in a tiny research study that involved only three patients.
Genetic Engineering - A Non-Toxic Treatment for Cancer
Leukemia is a cancer of the early blood-forming cells. Chronic lymphocytic leukemia (CLL), a type of cancer of white blood cell called the lymphocyte was studied in this study which resulted in 2 out of the 3 patients experiencing a complete remission of their cancerous leukemia, while the third showed only partial improvement.
Genetically Modified T Cells Obliterate Leukemia Tumors
The researchers used genetically engineered versions of the patients' own T cells to destroy at least two pounds of tumors in each patient in just three weeks. The T cell tumor treatment worked much better than even the researchers had expected, and was amazingly fast acting.
Unfortunately, this novel form of gene engineering is still in the development stages. The long-term health effects of the treatment is still under investigation and are unknown at this point. From a natural health perspective this type of revolutionary treatment method can be considered non-toxic because it didn't involve any use of chemotherapy, radiation therapy, or surgery.
The same study was published in two different research journals.
References:
- Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.
Porter DL, Levine BL, Kalos M, ...
N Engl J Med. 2011 Aug 25;365(8):725-33. Epub 2011 Aug 10.
PMID: 21830940 - T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced Leukemia.
Kalos M, Levine BL, Porter DL, ...
Sci Transl Med. 2011 Aug 10;3(95):95ra73.
PMID: 21832238
